-
Mashup Score: 2Pirtobrutinib Displays Activity in Relapsed/Refractory MCL Following Covalent BTK Inhibitor Therapy - 14 day(s) ago
Pirtobrutinib demonstrated promising efficacy and a tolerable safety profile in heavily pretreated patients with relapsed/refractory mantle cell lymphoma who received prior therapy with a covalent BTK inhibitor.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6About The Lancet Haematology - 17 day(s) ago
About
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 38Paper: Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access and Barriers to Chemoimmunotherapies and Transplant - 20 day(s) ago
Program: Oral and Poster Abstracts Session: 652. Multiple Myeloma: Clinic al and Epidemiological: Poster III Hematology Disease Topics & Pathways: Research, Clinical Practice (Health Services and Quality), Clinical Research, health disparities research, Diseases, Therapies Aytaj Mammadzadeh 1,2 *, Yara Shatnawi, MD 2,3 *, Rawan Atallah 2,4 *, Benlazar Mohamed, MD 5 *, Nihar Desai, MBBS 6 *, Shahrukh K Hashmi, MD, MPH 7,8 *, Thiago Xavier Carneiro, MD 9 *, Hira Shaikh, MBBS 2,10 *, Christopher Strouse, MD
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access & Barriers to Chemoimmunotherapies & Transplant worldwide https://t.co/08cRofbwXn ?ACCESS DENIED ? @OncoAlert #ASH23 @smbenlazar @nihardesai7 @hiragss @strouse_chris @DrRakeshPopat @kczmj @NausheenAhmedMD… https://t.co/F72cECoSoz https://t.co/blMGSYkD5n
-
-
Mashup Score: 6About The Lancet Haematology - 24 day(s) ago
About
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 10Meeting News | Blood Cancers Today - 25 day(s) ago
The online home of the latest conference coverage and meeting news for hematologic oncologists. View the latest news on Blood Cancers Today.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 6About The Lancet Haematology - 27 day(s) ago
About
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6About The Lancet Haematology - 30 day(s) ago
About
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 10Meeting News | Blood Cancers Today - 1 month(s) ago
The online home of the latest conference coverage and meeting news for hematologic oncologists. View the latest news on Blood Cancers Today.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 11Dr. Mikhael on Challenges, Advances in Multiple Myeloma Treatment | Blood Cancers Today - 1 month(s) ago
Dr. Mikhael reflected on how the BOSTON and STOMP studies impacted the myeloma treatment paradigm.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 2
The REVEAL study identified five risk factors, including leukocytosis, duration of time with PV, and more.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
Pirtobrutinib Displays Activity in Relapsed/Refractory MCL Following Covalent BTK Inhibitor Therapy. @jonathonbcohen @WinshipAtEmory @ASH_hematology #ASH23 https://t.co/JQHIi5EMI1